New treatments for severe asthma Source: Eur Respir Mon 2011; 51: 268-281 Year: 2011
Combined effect of anti-IgE (omalizumab) and specific immunotherapy (SIT) on in vitro release of leukotrienes (LT) and the cytokines IL-4 and interferon-gamma (IFN) Source: Eur Respir J 2002; 20: Suppl. 38, 588s Year: 2002
Preclinical development of an IL-13 neutralising antibody, CAT-354, for the treatment of human asthma Source: Eur Respir J 2005; 26: Suppl. 49, 367s Year: 2005
Monoclonal anti-interleukin-5 treatment suppresses eosinophil but not T-cell functions Source: Eur Respir J 2003; 21: 799-803 Year: 2003
The effect of anti-IL-5 therapy on sputum cells and cytokines in asthmatics Source: International Congress 2019 – Treatment of asthma with monoclonal antibodies Year: 2019
Pro- and anti-inflammatory cytokines TNF-alpha, IFN-gamma, IL-10 and TGF-beta1 levels in blood serum as markers of plasmaferesis success and inflammation activity in lung sarcoidosis (LS) Source: Eur Respir J 2006; 28: Suppl. 50, 676s Year: 2006
Cytokine modulators as novel therapies for airway disease Source: Eur Respir J 2001; 18: 67S-77S Year: 2001
LSC - 2019 - IL-4, IL-8, IL-13, IL-17, IL-33 serum levels changes in acute allergic asthma model Source: International Congress 2019 – Novel insights from in vitro and in vivo models of lung disease Year: 2019
IL-10 and IL-1ra mediates OVA-induced Th2 airway allergic response at short and long-term Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury Year: 2013
Complementary effects on IL-1, IL-6, TNF-alpha of salmeterol and/or montelukast added to fluticasone in moderate asthmatics Source: Eur Respir J 2004; 24: Suppl. 48, 580s Year: 2004
Serum TNF-a, IL-12 and IL-13 levels in severe bronchial asthma patients Source: Eur Respir J 2004; 24: Suppl. 48, 353s Year: 2004
The role of ECP, IL-4 and IL-5 in asthmatic patients Source: Eur Respir J 2003; 22: Suppl. 45, 292s Year: 2003
The interleukin-13 paradox in asthma: effective biology, ineffective biologicals Source: Eur Respir J, 53 (2) 1802250; 10.1183/13993003.02250-2018 Year: 2019
Cytokines in asthma Source: Eur Respir J 2001; 18: 24S-33S Year: 2001
IL-4, IFN-gamma and TNF-alpha levels in serum of patients with COPD, bronchial asthma and GERD Source: Annual Congress 2012 - Inflammatory mechanisms in COPD Year: 2012
The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics Source: Eur Respir J 2001; 18: 254-261 Year: 2001
The concentration of IL-2, IL-4, IL-6 and IFNγ in nasal secretion in respiratory atopy and pseudoatopy Source: Eur Respir J 2005; 26: Suppl. 49, 485s Year: 2005
Regular salbutamol use increases CXCL8 responses in asthma: relationship to the eosinophil response Source: Eur Respir J 2003; 22: 118-126 Year: 2003
The new approaches to the oral corticosteroid dosage decrease in patients with severe steroid-resistant bronchial asthma Source: Annual Congress 2005 - Improving asthma control in the harder-to-reach population Year: 2005
Levels of interleukins IL-4, IL-6, IL-8 and TNFa in sera of patients with tuberculosis before and during treatment Source: Eur Respir J 2002; 20: Suppl. 38, 556s Year: 2002